Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Health Serv Res. 2021 Dec;56(6):1245-1251. doi: 10.1111/1475-6773.13673. Epub 2021 May 18.
To quantify discrepancies between opioid prescribing and dispensing via the percentage of patients with Electronic Medical Record (EMR) prescriptions who subsequently filled the prescription within 90 days, defined as congruence, and compared opioid congruence with related medications.
Deidentified data from the IBM MarketScan Explorys Claims-EMR Dataset.
In this retrospective, observational study, we examined congruence for commonly prescribed controlled substances-opioids, stimulants, and benzodiazepines. Congruence was stratified by age group and sex.
DATA COLLECTION/EXTRACTION METHODS: Continuously enrolled adults aged 18-64 years with an EMR encounter (excluding inpatient settings) and ≥ 1 prescription for selected classes between 1/1/2016 and 10/2/2017.
During the study period, 1,353,478 adults had ≥1 EMR encounter. Patients with stimulants prescriptions had the highest congruence (83%) corresponding to 7151 claims for 8,635 EMR prescriptions, followed by opioids (66%; 62,766/95,690) and benzodiazepines (64%; 30,181/47,408). Chi-square testing showed congruence differed by age group within opioids (P < .0001) and benzodiazepines (P < .0001) and was higher among females within benzodiazepines (P < .0001).
These findings demonstrate that relying on claims data alone for opioid prescribing measures might underestimate actual prescribing magnitude by as much as one-third in these data. Combined EMR and claims data can help future research better understand characteristics associated with congruence or incongruence between prescribing and dispensing.
通过电子病历 (EMR) 处方中随后在 90 天内填写处方的患者比例(定义为一致性)量化阿片类药物处方与配药之间的差异,并将阿片类药物一致性与相关药物进行比较。
来自 IBM MarketScan Explorys Claims-EMR 数据集的匿名数据。
在这项回顾性观察研究中,我们检查了常用受控物质 - 阿片类药物、兴奋剂和苯二氮䓬类药物的一致性。一致性按年龄组和性别分层。
数据收集/提取方法:连续招募年龄在 18-64 岁之间的成年人,他们在 1/1/2016 至 10/2/2017 期间至少有一次 EMR 就诊(不包括住院环境)和至少有一次选定类别的处方。
在研究期间,1353478 名成年人至少有一次 EMR 就诊。使用兴奋剂处方的患者一致性最高(83%),对应 7151 份索赔和 95690 份 EMR 处方中的 8635 份,其次是阿片类药物(66%;62766/95690)和苯二氮䓬类药物(64%;30181/47408)。卡方检验显示,阿片类药物和苯二氮䓬类药物的年龄组之间的一致性存在差异(P<.0001),苯二氮䓬类药物中女性的一致性更高(P<.0001)。
这些发现表明,仅依靠索赔数据来衡量阿片类药物的处方措施可能会低估这些数据中实际处方的幅度,多达三分之一。EMR 和索赔数据的结合可以帮助未来的研究更好地了解与处方和配药之间一致性或不一致性相关的特征。